Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs ❯GLP-1 Agonists

Zepbound

Ozempic Shows Promise Beyond Diabetes Treatment

New studies suggest potential benefits for dementia, addiction, and cardiovascular health.

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales